What Is Driving the Interferon Beta Drugs Market Growth?
Interferon beta drugs are immunomodulatory agents used primarily to treat multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. These drugs—including interferon beta-1a and interferon beta-1b—reduce relapse rates, slow disability progression, and decrease the frequency of lesions in MS patients. The market for interferon beta drugs is evolving,...
0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр